Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guizhi Zhu

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Advanced Drug Delivery Reviews|August 21, 2018
Aptamer-based targeted therapyGuizhi Zhu, Xiaoyuan Chen
International Journal of Pharmaceutics|April 10, 2023
Nucleic acid immunotherapeutics and vaccines: A promising approach to glioblastoma multiforme treatmentLauren Dain, Guizhi Zhu
Bioconjugate Chemistry|June 18, 2015
Aptamer-Drug ConjugatesGuizhi Zhu, Gang Niu, Xiaoyuan Chen
Nanoscale|December 17, 2021
Pulmonary delivery of mucosal nanovaccinesWei Tang, Yu Zhang, Guizhi Zhu
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2025
Investigation of the impact of lipid nanoparticle compositions on the delivery and T cell response of circRNA vaccineYasir Alshehry, Xiang Liu, Yu Zhang, et al.
Biophysics Reports|August 2, 2021
ExoHCR: a sensitive assay to profile PD-L1 level on tumor exosomes for immunotherapeutic prognosisLujun Hu, Wenjie Chen, Shurong Zhou, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|November 30, 2013
Phthalocyanine-based organometallic nanocages: properties and gas storageGuizhi Zhu, Yawei Li, Kun Lü, et al.
The Journal of Physical Chemistry. A|December 17, 2013
Anisotropic Mo2-phthalocyanine sheet: a new member of the organometallic familyGuizhi Zhu, Min Kan, Qiang Sun, et al.
Physical Chemistry Chemical Physics : PCCP|June 18, 2016
Assembling a bi-coordinated Cr complex for ferromagnetic nanorings: insight from first-principles calculationsGuizhi Zhu, Junyi Liu, Qiang Sun, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Engineering circular guide RNA and CRISPR-Cas13d-encoding mRNA for the RNA editing of <i>Adar1</i> in triple-negative breast cancer immunotherapyShurong Zhou, Suling Yang, Jie Xu, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Advanced Drug Delivery Reviews|August 21, 2018
Aptamer-based targeted therapyGuizhi Zhu, Xiaoyuan Chen
International Journal of Pharmaceutics|April 10, 2023
Nucleic acid immunotherapeutics and vaccines: A promising approach to glioblastoma multiforme treatmentLauren Dain, Guizhi Zhu
Bioconjugate Chemistry|June 18, 2015
Aptamer-Drug ConjugatesGuizhi Zhu, Gang Niu, Xiaoyuan Chen
Nanoscale|December 17, 2021
Pulmonary delivery of mucosal nanovaccinesWei Tang, Yu Zhang, Guizhi Zhu
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2025
Investigation of the impact of lipid nanoparticle compositions on the delivery and T cell response of circRNA vaccineYasir Alshehry, Xiang Liu, Yu Zhang, et al.
Biophysics Reports|August 2, 2021
ExoHCR: a sensitive assay to profile PD-L1 level on tumor exosomes for immunotherapeutic prognosisLujun Hu, Wenjie Chen, Shurong Zhou, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|November 30, 2013
Phthalocyanine-based organometallic nanocages: properties and gas storageGuizhi Zhu, Yawei Li, Kun Lü, et al.
The Journal of Physical Chemistry. A|December 17, 2013
Anisotropic Mo2-phthalocyanine sheet: a new member of the organometallic familyGuizhi Zhu, Min Kan, Qiang Sun, et al.
Physical Chemistry Chemical Physics : PCCP|June 18, 2016
Assembling a bi-coordinated Cr complex for ferromagnetic nanorings: insight from first-principles calculationsGuizhi Zhu, Junyi Liu, Qiang Sun, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Engineering circular guide RNA and CRISPR-Cas13d-encoding mRNA for the RNA editing of <i>Adar1</i> in triple-negative breast cancer immunotherapyShurong Zhou, Suling Yang, Jie Xu, et al.
Pageof 12